Journal Article

PTEN and DNA Ploidy Status by Machine Learning in Prostate Cancer

Wæhre, Håkon, Askautrud, Hanne A., Kalsnes, Joakim, Cyll, Karolina, Danielsen, Håvard E., Kleppe, Andreas, Pradhan, Manohar, Tobin, Kari Anne R., Reine, Trine M., Hveem, Tarjei S., Brennhovd, Bjørn, Skaaheim Haug, Erik, Kildal, Wanja, Vlatkovic, Ljiljana

2021

Overview

Machine learning (ML) is expected to improve biomarker assessment. Using convolution neural networks, we developed a fully-automated method for assessing PTEN protein status in immunohistochemically-stained slides using a radical prostatectomy (RP) cohort (n = 253). It was validated according to a predefined protocol in an independent RP cohort (n = 259), alone and by measuring its prognostic value in combination with DNA ploidy status determined by ML-based image cytometry. In the primary analysis, automatically assessed dichotomized PTEN status was associated with time to biochemical recurrence (TTBCR) (hazard ratio (HR) = 3.32, 95% CI 2.05 to 5.38). Patients with both non-diploid tumors and PTEN-low had an HR of 4.63 (95% CI 2.50 to 8.57), while patients with one of these characteristics had an HR of 1.94 (95% CI 1.15 to 3.30), compared to patients with diploid tumors and PTEN-high, in univariable analysis of TTBCR in the validation cohort. Automatic PTEN scoring was strongly predictive of the PTEN status assessed by human experts (area under the curve 0.987 (95% CI 0.968 to 0.994)). This suggests that PTEN status can be accurately assessed using ML, and that the combined marker of automatically assessed PTEN and DNA ploidy status may provide an objective supplement to the existing risk stratification factors in prostate cancer.

• Publisher: MDPI AG,MDPI
• Subject: Biomarkers / Chromosomes / Cytometry / Deep learning / Deoxyribonucleic acid / Diploids / DNA / Learning algorithms / Machine learning / Medical prognosis / Neural networks / Patients / Ploidy / Prostate cancer / Prostatectomy / PTEN protein / Software / Surgeons / Survival analysis / Tumors